Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carol B Toris

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|October 5, 2021
The Effects of Topical Timolol and Latanoprost on Calculated Ocular Perfusion Pressure in Nonglaucomatous VolunteersAjay Kolli, Carol B Toris, David M Reed, et al.
Investigative Ophthalmology & Visual Science|August 29, 2006
The prostanoid EP2 receptor agonist butaprost increases uveoscleral outflow in the cynomolgus monkeySiv F E Nilsson, Enken Drecoll, Elke Lütjen-Drecoll, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|April 27, 2019
A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery MethodDavid F Woodward, Jenny W Wang, Robert A Coleman, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 11, 2018
Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive MonkeysMasahiro Fuwa, Carol B Toris, Shan Fan, et al.
Experimental Eye Research|March 15, 2011
Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating prostaglandin F2α agonist, in preclinical modelsAchim H P Krauss, Francesco Impagnatiello, Carol B Toris, et al.
American Journal of Ophthalmology|February 23, 2019
Effect of Timolol on Aqueous Humor Outflow Facility in Healthy Human EyesArash Kazemi, Jay W McLaren, Matthew G J Trese, et al.
Investigative Ophthalmology & Visual Science|March 11, 2021
NCX 667, a Novel Nitric Oxide Donor, Lowers Intraocular Pressure in Rabbits, Dogs, and Non-Human Primates and Enhances TGFβ2-Induced Outflow in HTM/HSC ConstructsElena Bastia, Carol B Toris, Stefania Brambilla, et al.
Ophthalmology. Glaucoma|September 12, 2022
Eye Dynamics and Engineering Network Consortium: Baseline Characteristics of a Randomized Trial in Healthy AdultsDavid M Reed, Carol B Toris, Jesse Gilbert, et al.
Ophthalmology|December 8, 2004
Detection of the free acid of bimatoprost in aqueous humor samples from human eyes treated with bimatoprost before cataract surgeryCarl B Camras, Carol B Toris, Birgitta Sjoquist, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|April 27, 2010
A novel nitric oxide releasing prostaglandin analog, NCX 125, reduces intraocular pressure in rabbit, dog, and primate models of glaucomaValentina Borghi, Elena Bastia, Massimiliano Guzzetta, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|October 5, 2021
The Effects of Topical Timolol and Latanoprost on Calculated Ocular Perfusion Pressure in Nonglaucomatous VolunteersAjay Kolli, Carol B Toris, David M Reed, et al.
Investigative Ophthalmology & Visual Science|August 29, 2006
The prostanoid EP2 receptor agonist butaprost increases uveoscleral outflow in the cynomolgus monkeySiv F E Nilsson, Enken Drecoll, Elke Lütjen-Drecoll, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|April 27, 2019
A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery MethodDavid F Woodward, Jenny W Wang, Robert A Coleman, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 11, 2018
Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive MonkeysMasahiro Fuwa, Carol B Toris, Shan Fan, et al.
Experimental Eye Research|March 15, 2011
Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating prostaglandin F2α agonist, in preclinical modelsAchim H P Krauss, Francesco Impagnatiello, Carol B Toris, et al.
American Journal of Ophthalmology|February 23, 2019
Effect of Timolol on Aqueous Humor Outflow Facility in Healthy Human EyesArash Kazemi, Jay W McLaren, Matthew G J Trese, et al.
Investigative Ophthalmology & Visual Science|March 11, 2021
NCX 667, a Novel Nitric Oxide Donor, Lowers Intraocular Pressure in Rabbits, Dogs, and Non-Human Primates and Enhances TGFβ2-Induced Outflow in HTM/HSC ConstructsElena Bastia, Carol B Toris, Stefania Brambilla, et al.
Ophthalmology. Glaucoma|September 12, 2022
Eye Dynamics and Engineering Network Consortium: Baseline Characteristics of a Randomized Trial in Healthy AdultsDavid M Reed, Carol B Toris, Jesse Gilbert, et al.
Ophthalmology|December 8, 2004
Detection of the free acid of bimatoprost in aqueous humor samples from human eyes treated with bimatoprost before cataract surgeryCarl B Camras, Carol B Toris, Birgitta Sjoquist, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|April 27, 2010
A novel nitric oxide releasing prostaglandin analog, NCX 125, reduces intraocular pressure in rabbit, dog, and primate models of glaucomaValentina Borghi, Elena Bastia, Massimiliano Guzzetta, et al.
Pageof 9